Meeting of the SWAG Network Haematology SSG
|
|
- Dwight Dixon
- 5 years ago
- Views:
Transcription
1 Meeting of the SWAG Network Haematology SSG Tuesday 21 st November 2017, 14:00-16:30 Penny Brohn Cancer Care, Chapel Pill Lane, Pill, Bristol, BS20 0HH This meeting was sponsored by Celgene and Novartis Chair: Dr Deepak Mannari (DM) NOTES (To be agreed at the next SSG Meeting) ACTIONS 1. Welcome and apologies Please see the separate list of attendees and apologies uploaded on to the SWCN website here. 2. Living with and beyond cancer 2.1 Implementation of the recovery package Presented by Catherine Neck (CN) The risk stratified lymphoma guidelines, circulated prior to the meeting, had been amended according to advice from lymphoma fellow Karan Wadhera and feedback from CNS teams in the region. They reflected the fact that the majority of remissions were most likely to occur within the first 2 years of treatment. Clinicians in Bristol and Weston had been using the pathway for patients who were able to self-monitor for signs and symptoms, and this seemed to work well to safely reduce follow up. It was recognised that there would always be a cohort of patients who would not be suitable to discharge to self-monitoring. The most important factor is to ensure that there is rapid access back into the service should signs and symptoms be identified by the patient; GPs should be aware of the process to enable this. The pathway will be recirculated for further comments aiming to reach a consensus across the region by the 2 nd week in December. CN/ It would be helpful if the clinical team could verify where it may, or may not, be appropriate to streamline follow up of other haematology disease areas so that this evidence is available should commissioners propose streamlining the service. In the opinion of the user representative member, it is important to clarify the potential late effects from treatment and have capacity to gain access back into the service when required. Patients may also wish for a regular follow up schedule for social reasons. It is important to manage patients expectations of the pathway from the outset; Page 1 of 5
2 patients have reported feeling very reassured when reaching the point where they can be discharged from regular follow up. 3. Review of previous meeting s notes and actions The last meeting was held prior to the annual lymphoma education event in March to consolidate the time spent travelling and attending external meetings. This will be repeated in March from 2:00-4:30 to ensure that there is sufficient time between the meetings. Notes: As there were no amendments or comments following distribution of the notes from the meeting on Wednesday 3 rd March 2017, the notes were accepted. Actions: A date for a research break-out meeting will be decided prior to the next SSG meeting. Funding for the chemotherapy protocol work will continue until the end of March Continued funding after this period will need to be clarified. A direct link to the GP guidelines will be circulated; they were difficult to locate from the home page of the SWCN website. Use of the guidelines on the website had increased since the suspected cancer referral form had been published, and will continue to be monitored. The MDT in Musgrove Park had reviewed the CRUK MDT effectiveness report again since the last meeting. The MDT was currently overloaded with discussion of every patient at each stage; this was not considered the best use of MDT members time, in particular for radiologists. Ideally the provisional MDT list should be checked prior to the meeting to ensure that all necessary information is available. Points in the treatment pathway where an MDT review was required could be agreed, and radiology and pathology specialist sections could be arranged so that there was no need for these MDT members to stay for the duration of the meeting. Professor Martin Gore has been tasked with transforming the work of cancer MDTs and had circulated a proposal about this work; this will be recirculated to the regional MDT Leads. Some interim scans could be reviewed outside MDTs, but a safety net would be required to ensure that no one was missed and this would need to be audited every three months. Listing scans for MDT discussion was sometimes used as a method to get the scan rapidly reviewed; radiologists should be informed about how this plan could have the potential to reduce their MDT attendance time. Teams were implementing some of the recommendations from the virology audit presented at the last meeting. The team in Gloucestershire had a system to flag up when to test for Hepatitis, but didn t have the same system for HIV; Richard Lush Page 2 of 5
3 will investigate how this can be amended. RL 4. Chemotherapy protocols update Please see the separate table of protocols, for update, circulated with the notes. Bisphosphonate Guidelines for the BHOC had been circulated for potential agreement across the network; all present agreed to adopt the guidelines. It was decided that the transplant protocols did not need to be available on the website. The word indolent had been removed from the lymphoma section on the website. The hairy cell leukaemia section could also be removed. 5. Patient experience Agreed 5.1 National Cancer Patient Experience Survey (NCPES) results and CNS update Presented by Sian Middleton / CNS team The NCPES 2016 results, posted to inpatients and day case cancer patients between April and June 2016 and published in July 2017, were reviewed in comparison with the national average and 2015 results. Results had not been published for Yeovil as less than 21 responses were received. Some of the results were marginally worse than the year before, and some were marginally better. There were also results attributed to haematology services that were actually related to oncology. The relevance of the survey was questioned; results were always a year behind the current service so it was difficult to draw any conclusions. It was decided that it would be more useful for each CNS teams to identify 3 priorities for improvement for a more focussed discussion at a future meeting. CNS teams Results of the NCPES can be useful to use as evidence in business cases for the CNS workforce when related results are low. The question has anyone asked you whether you would like to take part in cancer research? was considered confusing as this would not be discussed with patients if there was not a relevant trial available. Lead Cancer Nurse Ruth Hendy has written an article on how to interpret the NCPES results which will be circulated. The patient experience support group in Taunton provides patient experience responses with far more value. Page 3 of 5
4 6. Quality indicators, audits and data collection 6.1 Network audit ideas Results of the virology network audit have been circulated to SSG members and the Cancer Service Managers. Nik Chavda and Andrea Preston are currently doing a retrospective analysis of the efficacy of Colesevelam at BHOC for Lenalidomide induced diarrhoea. SSG members who are interested in contributing data should andreadahlgren@hotmail.com or call Further audit ideas: Provision of end of treatment summaries; Sophie Otton (SO) will produce an audit proforma and the project will be launched at the next meeting Use of Bisphosphonates and dental health reviews Intrathecal CNS prophylaxis for high grade lymphoma; Chris Knechtli (CK) will produce an audit proforma, to be completed with 6 months of retrospective data, for circulation prior to the next meeting Two week wait referral conversion rates 3 months pre and post publication of the new suspected cancer referral forms will be undertaken by Cancer Manager Zena Lane (ZL) Regional use of REVLIMID; Helen Dunderdale () will submit signed data sharing agreements to Celgene. SO? CK ZL It was noted that the following sentence on the new suspected cancer referral form: A polyclonal (diffuse) increase in gammaglobulin is not associated with haematological malignancy, should be amended to: A polyclonal (diffuse) increase in gammaglobulin is not associated with myeloma. The link to GP guidelines should also be amended to state: Please access the GP guidelines for frequently asked questions. The BNSSG have removed the serum free light chain assay (SFLCA) from the form and replaced this with urinary Bence-Jones protein, as SFLCA is not available in the North Bristol Trust laboratory. It should be made clear that the test is available elsewhere in the region. The issues will be fed back to the CCGs who plan to review the forms in approximately 6 months time. 6.2 Clinical trials update Presented by Helen Dunderdale Research Delivery Manager for the West of England Clinical Research Network, David Rea (DR), has sent his apologies and supplied a presentation on the research activity across the region. Page 4 of 5
5 The recruitment target per 100,000 population for haematological malignancies is 7; this will increase by 10% year on year. Recruitment to date had already exceeded the 2017/18 target. The reason for the 10% increase, and if the recruitment figures relate to the adult service or are combined with recruitment from the paediatric oncology team, will be established. /DR SSG members can contact DR if they would like to undertake training on use of the online resources for research; links to these are available in the presentation. Information on open trials including eligibility criteria will be made available on the SWCN website for review within the MDT. The list of trials in set-up is to be checked for completeness as there is often a time lag between submitting an interest in setting up a trial and the NIHR knowing about it. It would be helpful to have an estimated opening date on the list. A simplified process was required to avoid local duplication when translating trial protocols into standard operating procedures for pharmacists and local teams to interpret. This will be raised with the clinical research network. DM/ 7. Clinical guidelines Algorithms of treatment pathways will be produced for each disease type; a Hodgkin s Lymphoma pathway has been drafted. Novartis have offered to assist with formatting these once the content has been decided. This will be included in the Work Programme. Following the biennial review of the SWAG Clinical Guidelines, the content had been reduced from a 60 page document to 12 pages, now containing links to all relevant national guidelines. The new format was agreed, and the link to the document, found here, is to be saved to SSG members bookmarked web pages. DM/ Agreed 8. Any other business AP has escalated the issue of non-medical prescribers not being able to complete prescription authorisation forms for IMiDs to the National Medicines Optimisation Group, who are actively working on this. It is not clear how many other centres have nurses or pharmacists who are affected; the group will be kept updated of any changes with the MHRA and the SSG could further escalate the issue. The Teenage and Young Adult (TYA) fertility sparing/preservation pathway needs to be clarified. Musgrove Park is no longer able to refer patients to Exeter and the fertility service at Southmead Hospital has recently been decommissioned. The RUH currently refer patients to Oxford. Consultant Paediatric Oncologist Rachel Dommett will be contacted to seek clarification. AP DM/ Access to blood volume testing varied across the region and has nearly been phased out; Birmingham and Plymouth are thought to be able to offer the service. Date of next meeting: Wednesday 7th March 2018, The Castle Hotel, Taunton. Page 5 of 5
South West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services
Meeting of the SWAG Network Haematology Site Specific Group (SSG) Wednesday 2 nd November 2016, 14.00-16.30 Engineers House Conference Centre, Clifton Down, Bristol Chair: Dr Deepak Mannari (DM) This meeting
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Haematology Cancer Network Site Specific Group.
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Haematology Cancer Network Site Specific Group Annual Report 2014 Version 1.0 1 This annual report was prepared by: Sophie Otton Chair
More informationPlease see the separate list of attendees and apologies uploaded on to the South West Clinical Network website here.
Meeting of the SWAG Network Colorectal Site Specific Group (SSG) 09:30-15:00, Wednesday, 7 th June 2017 Taunton Hyde Park Conference Centre, Hyde Lane, Taunton, Somerset, TA2 8BU Chair: Mr Michael Williamson
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Meeting of the SWAG Network Urology SSG Thursday 15 th March 2018, 13:30-17:00 Spire Specialist Care Centre, 300 Park Avenue, Aztec West Almondsbury, Bristol, BS32 4SY Chairs: Mr Jaspal Phull (JP) & Ms
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Meeting of the SWAG Network Skin Cancer Site Specific Group (SSG) Wednesday 23 rd May 2018, 09:30-13:30 Penny Brohn Cancer Care, Chapel Pill Lane, Pill, Bristol, BS20 0HH This meeting was sponsored by
More informationSouth West Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services
Meeting of the SWAG Network Colorectal SSG 09:30-15:30, Wednesday, 30 th November 2016 Penny Brohn Cancer Care, Chapel Pill Lane, Pill, BS20 OHH THIS MEETING WAS SPONSORED BY NORGINE, MERCK SERONO AND
More informationNational Cancer Registration Service South West Cancer Alliance Manager NHS England South, South West
Present : Apologies: Meeting of the SWAG Area Cancer Operational Group (formerly ASW) Held on Wednesday 18 th April 2018, 10.00-12.00 Sanford Education Centre, Room 10, 32 Keynsham Road, Cheltenham, GL53
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Soft Tissue Sarcoma Network Site Specific Group. Constitution.
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Soft Tissue Sarcoma Network Site Specific June 2017 Revision due: April 2019 Page 1 of 23 VERSION CONTROL THIS IS A CONTROLLED DOCUMENT.
More informationHaemato-oncology Clinical Forum. 20 th June 2013
Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for
More information2. Review of previous notes
Meeting of the SWAG Network Colorectal Site Specific Group (SSG) Wednesday, 27 th June 2018, 09:30-15:30 Penny Brohn Cancer Care, Chapel Pill Lane, Pill, Bristol, BS20 0HH THIS MEETING WAS SPONSORED BY
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Meeting of the SWAG Network Gynae SSG Friday 15 th June 2018, 15:30-18:30, Board Room, Trust Headquarters, Bristol Royal Infirmary, Bristol, BS1 3NU THIS MEETING WAS SUPPORTED BY ASTRAZENECA AND STRYKER
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician ASWCN TAUNTON AND SOMERSET Taunton Lung MDT (11-2C-1) - 2011/12 Dr Sarah Foster Compliance Self Assessment LUNG MDT
More informationDeveloping Services for Teenagers and Young Adults (TYA) with Cancer
Selena Riggs South West Specialised Commissioning Group Deirdre Brunton- Teenage Cancer Trust, TYA Lead Nurse Developing Services for Teenagers and Young Adults (TYA) with Cancer South West Specialised
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Brain and CNS Cancer Network Site Specific Group.
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Brain and CNS Cancer Network Site Specific Group Annual Report 2015 Version 1.0 1 This Annual Report was prepared by: Venkat Iyer, Chair
More informationLCA Lung Clinical Forum. 21 st October 2014
LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for
More informationEstablished by NHS England in 2013, we are one of 15 AHSNs across England established to spread innovation at pace and scale.
Friday 22 June 2018 @WEAHSN 1 Overview About the West of England Academic Health Science Network The West of England AHSN is delivering positive healthcare outcomes locally and nationally by driving the
More informationUrology Pathway Board Meeting Minutes of the meeting held on March 15 th 2017
Greater Manchester Cancer Urology Pathway Board Urology Pathway Board Meeting Minutes of the meeting held on March 15 th 2017 Members in attendance Satish Maddineni (Chair) Pathway Director Steve Elliot
More informationSouth West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services
Meeting of the SWAG Network Colorectal Site Specific Group (SSG) 10:00 16:00, Wednesday, 22nd April 2015, South West House, Blackbrook Park Avenue, Taunton, TA1 2PX Chair: Mr Michael Williamson (MW) This
More informationSCAN Haematology Group Wednesday 23 rd May 2012 Telepresence Room, Western General Hospital, Edinburgh with videolinks to Borders, VHK and St John s
DRAFT SCAN Haematology Group Wednesday 23 rd May 2012 Telepresence Room, Western General Hospital, Edinburgh with videolinks to Borders, VHK and St John s MINUTES Present Sandra Bagnall Liz Brown Mira
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT NECN N Tees & Hartlepool North Tees And Hartlepool Date Self Assessment Completed 23rd July 2009 Date of IV Review 19th June 2009
More informationGuideline for the Follow-up of Patients with Gynaecological Malignancies
Guideline for the Follow-up of Patients with Gynaecological Malignancies Version History Version Date Summary of Change/Process 2.0 20.02.08 Endorsed by the Governance Committee 2.1 18.11.10 Circulated
More informationSTAKEHOLDER CONSULTATION
STAKEHOLDER CONSULTATION DRAFT NSW CANNABIS MEDICINES PRESCRIBING GUIDANCE BACKGROUND Many Australians are now able to access cannabinoids for medicinal purposes under the supervision of a medical practitioner.
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance
Meeting of the SWAG Network Urology SSG Thursday 5 th July 2018, 13:30-17:00 Spire Specialist Care Centre, 300 Park Avenue, Aztec West Almondsbury, Bristol, BS32 4SY Chairs: Mr Jaspal Phull (JP) & Ms Lucinda
More informationREPORT ON PROSPECTIVE AUDIT OF LYMPHOMA PATIENTS BORDERS, FIFE, AND LOTHIAN DIAGNOSED IN 2008
SE Scotland Cancer Network SCAN AUDIT REPORT ON PROSPECTIVE AUDIT OF LYMPHOMA PATIENTS BORDERS, FIFE, AND LOTHIAN DIAGNOSED IN 2008 Reports prepared by: Christine Maguire SCAN Cancer Audit Facilitator
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Cancer of Unknown Primary Network Site Specific Group. Clinical Guidelines
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Cancer of Unknown Primary Network Site Specific Group Revision due: April 2019 Page 1 of 11 VERSION CONTROL THIS IS A CONTROLLED DOCUMENT.
More informationSouth West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services
SWAG Cancer of Unknown Primary (CUP) Referral Processes The SWAG network site specific groups refer any patient with metastatic carcinoma of unknown origin on for discussion to the specialist carcinoma
More informationACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report
ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two
More informationClinical Commissioning Policy: Chemotherapy Algorithms for Adults and Children. January 2013 Reference: NHS England XXX/X/X.
Clinical Commissioning Policy: Chemotherapy Algorithms for Adults and Children January 2013 Reference: NHS England XXX/X/X England 1 NHS England Clinical Commissioning Policy: Chemotherapy Algorithms for
More informationNational Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator
National Cancer Peer Review Sarcoma Julia Hill Acting Deputy National Co-ordinator Improving Outcomes Guidance The Intentions of Improving Outcomes for People with Sarcoma Changes in the provision of care
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Breast Cancer Network Site Specific Group. Constitution.
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Breast Cancer Network Site Specific Group Constitution June 2015 Revision due: April 2016 Page 1 of 20 VERSION CONTROL THIS IS A CONTROLLED
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Head and Neck Cancer Network Site Specific Group. Constitution.
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Head and Neck Cancer Network Site Specific Group Constitution August 2015 Revision due: April 2017 Page 1 of 24 VERSION CONTROL THIS
More informationNational Cancer Peer Review Programme
National Cancer Peer Review Programme Julia Hill Acting Deputy National Co-ordinator What is Cancer Peer Review? A quality assurance process for cancer services. An integral part of Improving Outcomes
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Cancer of Unknown Primary (CUP) Network Site Specific Group.
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Cancer of Unknown Primary (CUP) Network Site Specific Group Annual Report 2015 Version 1.0 1 This Annual Report was prepared by: Tania
More informationNewsletter Issue 9 June 2015
Newsletter Issue 9 June 2015 Dementia Improvement Group The Dementia Improvement Group met again at Taunton Racecourse on 4 th June. There was an unprecedented turnout of enthusiastic and committed stakeholders,
More informationLondon Cancer Pathway Board for Haematological Malignancies
Pathway Board for Haematological Malignancies Date: Thursday, 16 th August 16:30-18:00 Venue: Boardroom, 3 rd Floor, UCLP, 170 Tottenham Court Road, London W1T 7HA Chair: Dr Kirit Ardeshna ACTION LOG Action
More informationSCAN Skin Group Friday 1 st November 2013
SCAN Skin Group Friday 1 st November 2013 Dermatology Seminar Room, Lauriston Buildings with videolinks to Oncology Seminar Room, Western General Hospital and Borders General Hospital. MINUTES Present
More informationWessex Cancer Alliance. Wessex Cancer Strategic Clinical Network
Wessex Cancer Alliance Wessex Cancer Strategic Clinical Network Chair : Tim Billington Friday 11 th September 2015 Patients are our priority Patients are people Perception versus what is said Pathways
More informationSouth West Strategic Clinical Network Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services
Meeting of the SWAG Network Skin Cancer Site Specific Group (SSG) 17 th May 2016, Jurys Inn, Gloucester Road, Cheltenham, GL51 0TS, 09:30-13:00 This meeting was sponsored by DERMAL, PROSTRAKAN and BRISTOL
More informationActivity Report July 2012 June 2013
Urological Cancers Managed Clinical Network Activity Report July 2012 June 2013 Mr Seamus Teahan Consultant Urologist MCN Clinical Lead Tom Kane MCN Manager 1 CONTENTS EXECUTIVE SUMMARY 3 1. INTRODUCTION
More informationSarah Ambe Team Manager, Healthwatch Bristol SA Alison Bolam GP Clinical Commissioning Area Lead (Bristol), BNSSG AB
Patient and Public Involvement Forum Minutes of the meeting held on Tuesday 17 th July 2018 at 2pm in the WG Grace Meeting Room, Lower Ground Floor, South Plaza, Marlborough Street, Bristol, BS1 3NX Minutes
More informationSOMERSET PRESCRIBING FORUM
SOMERSET PRESCRIBING FORUM Minutes of the meeting held at Wynford House, Yeovil, on Wednesday 14 November 2012 Present Position Initials Chair, Drug & Therapeutics Committee, Taunton & Somerset NHS Foundation
More informationAcute Oncology Services Clinical Forum: Metastatic Spinal Cord Compression. Tuesday 17 th September 2013
Acute Oncology Services Clinical Forum: Metastatic Spinal Cord Compression Tuesday 17 th September 2013 Welcome, Introduction and Aims of the Event Dr Tom Newsom-Davis, LCA AOS Pathway Chair Why MSCC?
More informationSupra Network Sarcoma Advisory Group (SAG) Annual Report
London and South East Sarcoma Network Supra Network Sarcoma Advisory Group (SAG) Annual Report 2011-2012 Hosted by Date: December 2012 Version: 2 Review Date: September 2013 London Cancer Integrated Cancer
More informationTest and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire
Test and Learn Community Frailty Service for frail housebound patients and those living in care homes in South Gloucestershire Introduction This document introduces South Gloucestershire Clinical Commissioning
More informationBristol CCG Cancer Survivorship Consultation Event
Bristol CCG Cancer Survivorship Consultation Event Thursday 12 th February 2015 Armada House, Bristol Welcome Alison Moon Bristol CCG Director of Quality and Transformation Martin Jones Chair of Bristol
More informationActivity Report March 2013 February 2014
West of Scotland Cancer Network Skin Cancer Managed Clinical Network Activity Report March 2013 February 2014 Dr Girish Gupta Consultant Dermatologist MCN Clinical Lead Tom Kane MCN Manager West of Scotland
More informationLiving With & Beyond Cancer
Living With & Beyond Cancer Catherine Neck Macmillan Cancer Rehabilitation/ Recovery Package Project Lead, Avon & Somerset Emma Ryan Macmillan Project Manager, Living Well With & Beyond Cancer, Bristol
More informationFrom the Permanent Secretary and HSC Chief Executive
From the Permanent Secretary and HSC Chief Executive Dr Andrew Murrison MP Chair, N. Ireland Affairs Committee Committee Office House of Commons LONDON SW1A 0AA northircom@parliament.uk Castle Buildings
More informationNational Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer
National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation
More informationArea 062 Gyle Square 1 South Gyle Crescent Edinburgh EH12 9EB Telephone: Fax:
National Services Division Minutes Area 062 Gyle Square 1 South Gyle Crescent Edinburgh EH12 9EB Telephone: 0131 275 7546 Fax: 0131 275 7614 www.nsd.scot.nhs.uk www.sdsd.scot.nhs.uk Scottish Differences
More informationIntegrated Diabetes Care in Oxfordshire -patient's perspective. Avril Surridge
Integrated Diabetes Care in Oxfordshire -patient's perspective Avril Surridge Today How does diabetes care in Oxfordshire look like from a patient s perspective? Good things What could be improved? National
More informationPATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE
PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Dr V. Misra Version: Accountable Committee: V3 MSCC Network
More informationSELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)
SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) - 2011/12 Dr Angela Morgan
More informationDouglas Dorward 5 th Year Medical Student, University of Dundee NCIN Cancer Outcomes Conference, Birmingham 14 th June 2012
Douglas Dorward 5 th Year Medical Student, University of Dundee NCIN Cancer Outcomes Conference, Birmingham 14 th June 2012 Professor John Dewar - Professor in Clinical Oncology Ninewells Hospital, Dundee
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Sarcoma Specialist Multi Disciplinary Team for Suspected Sarcoma of Soft Tissue Extremities (limbs and trunk
More informationSWAG Cancer Alliance Programme Manager
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Alliance Minutes of the Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance Board Meeting held on Friday 9 th June 2017 10:00-12:00
More informationActivity Report April 2013 March 2014
North, South East and West of Scotland Cancer Networks HepatoPancreatoBiliary Cancers National Managed Clinical Network Activity Report April 2013 March 2014 Mr Colin McKay Consultant Surgeon NMCN Clinical
More informationPEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)
PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM) Network Organisation (Trust) Team DCN POOLE Poole THYROID ONLY MDT (11-2I-2) - 2011/12 Peer Review Visit Date 18th August 2011 Compliance THYROID ONLY
More informationNational Comparative Audit of Blood Transfusion Audit of Red Cell & Platelet Transfusion in Adult Haematology Patients.
National Comparative Audit of Blood Transfusion 2016 Audit of Red Cell & Platelet Transfusion in Adult Haematology Patients South West RTC Why was this audit necessary? Up to 65% of all platelet transfusions
More informationAcute Oncology & Chemotherapy Clinical Network Group (CNG)
Acute Oncology & Chemotherapy Clinical Network Group (CNG) Work Programme 2014-2015 Version 1.0 This Work Programme has been agreed by: Title Name Date Agreed AO & Chemotherapy CNG Chair Ernie Marshall
More informationTransforming Cancer Services for London
Programme Director Paul Roche Status Draft Owner Laura Boyd Version 0.4 Author Jennifer Layburn Date 15/05/13 Transforming Cancer Services for London Best Practice Commissioning Pathway for the early detection
More information1. RE-COMMISSIONING OF DRUG AND ALCOHOL TREATMENT AND RECOVERY SERVICES
Cabinet Member Decision 7 August 2014 1. RE-COMMISSIONING OF DRUG AND ALCOHOL TREATMENT AND RECOVERY SERVICES Relevant Cabinet Member Relevant Officer Recommendation Mr M J Hart Director of Adult Services
More informationActivity Report July 2014 June 2015
West of Scotland Cancer Network Gynaecological Cancer Managed Clinical Network Activity Report July 2014 June 2015 Nadeem Siddiqui Consultant Gynaecological Oncologist MCN Clinical Lead Kevin Campbell
More informationFramework on the feedback of health-related findings in research March 2014
Framework on the feedback of health-related findings in research March 2014 Summary Scope and background In the course of a study involving human participants, researchers may make a finding that has potential
More informationProgress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England
Report by the Comptroller and Auditor General Department of Health, NHS England and Public Health England Progress in improving cancer services and outcomes in England HC 949 SESSION 2014-15 15 JANUARY
More informationDelivering 62 Day GP Cancer Waits in a Complex Landscape. Hannah Marder Cancer Manager University Hospitals Bristol
Delivering 62 Day GP Cancer Waits in a Complex Landscape Hannah Marder Cancer Manager University Hospitals Bristol Overview The 62 day GP target Cancer pathways What causes breaches? Good practice and
More informationActivity Report April 2012 to March 2013
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2012 to March 2013 Professor Roy Rampling Emeritus Professor
More informationThis paper outlines the engagement activity that took place, and provides key themes from the 57 written responses received.
Agenda item: 5.4 Subject: Presented by: Prepared by: Submitted to: Specialist Fertility Services Dr Dustyn Saint SNCCG Commissioning Team SNCCG Communications and Engagement Team SNCCG Governing Body Date:
More informationGreater Manchester Cancer
Meeting at Manchester Royal Infirmary Date of Meeting: 30 November 2017 Chair: Mr Derek O Reilly Greater Manchester Cancer Attendance Derek O Reilly Rebecca Price Vicki Stephenson Hornby Neil Bibby Saurabh
More informationAcute Lymphoblastic Leukaemia Guidelines
Acute Lymphoblastic Leukaemia Guidelines Approved by Pathway Board for Haematological Malignancies Coordinating author: Adele Fielding, Royal Free London NHS Trust Date of issue: 12.03.2015 Version number:
More informationImproving services for upper GI (OG) cancer Application template (Version 2)
Trust Clinical lead Improving services for upper GI (OG) cancer Application template (Version 2) Managerial lead Date completed 14 June 2013 Barnet & Chase Farm Hospitals NHS Trust Dr Marta Carpani Upper
More informationTransforming Cancer Services Team
Transforming Cancer Services Team Healthy London Partnership Annual Report 2016/17 July 2017 Supported by and delivering for London s NHS, Public Health England and the Mayor of London Contents Who we
More informationHERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN
HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN 2016-2021 1 1. Introduction Herts Valleys Palliative and End of Life Care Strategy is guided by the End of Life Care Strategic
More informationImproving diagnostic pathways for patients with vague symptoms
Improving diagnostic pathways for patients with vague symptoms Executive summary Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis of cancer initiative supported by: NHS England, Cancer
More informationINTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM)
INTERNAL VALIDATION REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MVCN EAST AND NORTH HERTFORDSHIRE Mount Vernon Cancer Centre Cancer Network MDT (11-2K-1) - 2011/12 Date Self Assessment Completed
More informationVacancy list Pathway Boards
Vacancy list Pathway Boards The table below includes all the current vacancies for Pathway Boards. If you would like to apply to be a patient and carer representative on a Pathway Board, you need to have
More informationHCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report
HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report About HCV Action HCV Action is a network, co-ordinated by The Hepatitis C Trust, that brings together health professionals
More informationINTERNAL VALIDATION REPORT...
INTERNAL VALIDATION REPORT... Network Trust Team AngCN CAMBRIDGE UNIVERSITY HOSPITALS Addenbrookes Sarcoma Locality Measures (11-1D-1l) - 2011/12 Date Self Assessment Completed 30th November 2011 Date
More informationNICE Quality Standards and COF
NICE Quality Standards and COF David Baldwin Consultant Respiratory Physician NUH Hon Senior Lecturer Nottingham University Clinical lead NICE lung cancer GL Chair NICE QS Topic Expert Group Quality Standards
More informationSCAN Lung Group Wednesday 25 th September pm
DRAFT SCAN Lung Group Wednesday 25 th September 2013 14.15 16.15pm Telepresence Suite, Western General Hospital, Edinburgh with videolinks to Borders and Dumfries Present Sandra Bagnall Mimica Bjelogrlic
More informationWaiting Times for Suspected and Diagnosed Cancer Patients
Waiting Times for Suspected and Diagnosed Cancer Patients 2015-16 Annual Report Waiting Times for Suspected and Diagnosed Cancer Patients 1 Waiting Times for Suspected and Diagnosed Cancer Patients Prepared
More informationSomerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Head and Neck Cancer Network Site Specific Group. Constitution.
Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Head and Neck Cancer Network Site Specific Group Constitution June 2017 Revision due: April 2019 Page 1 of 23 VERSION CONTROL THIS IS
More informationHead and Neck Pathway Board 13 th January 2016 Minutes of Meeting
Head and Neck Pathway Board 13 th January 2016 Minutes of Meeting Humphrey booth Lecture theatre 2, Mayo building SRFT Time: 2-4pm Attendance Miss Susi Penney David Makin David Thomson Mazhar Iqbal Kate
More informationCase scenarios: Patient Group Directions
Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios
More informationRuth Howkins Deputy National Coordinator National Cancer Peer Review
Ruth Howkins Deputy National Coordinator National Cancer Peer Review Purpose of Peer Review To ensure services are as safe as possible To improve the quality and effectiveness of care To improve the patient
More informationFixing footcare in Sheffield: Improving the pathway
FOOTCARE CASE STUDY 1: FEBRUARY 2015 Fixing footcare in Sheffield: Improving the pathway SUMMARY The Sheffield Teaching Hospitals NHS Foundation Trust diabetes team transformed local footcare services
More informationThe Peninsula Network Site Specific Group for Thoracic Oncology
The Peninsula Network Site Specific Group for Thoracic Oncology Network Annual Report June 205 Acting Chair: Liz Toy Date Approved: Annual report of the Network Site Specific Group for Thoracic Oncology
More informationNational Standards for Acute Oncology Services
Cancer National Specialist Advisory Group National Standards for Acute Oncology Services June 2016 TABLE OF CONTENTS 1. PURPOSE... 2 2. INTRODUCTION... 2 3. STRATEGIC CONTEXT... 4 4. SCOPE OF ACUTE ONCOLOGY
More informationThe RPS is the professional body for pharmacists in Wales and across Great Britain. We are the only body that represents all sectors of pharmacy.
Royal Pharmaceutical Society 2 Ash Tree Court Woodsy Close Cardiff Gate Business Park Pontprennau Cardiff CF23 8RW Mr Mark Drakeford AM, Chair, Health and Social Care Committee National Assembly for Wales
More informationNetworking for success: A burning platform in Berkshire West
SERVICE REDESIGN CASE STUDY 1: NOVEMBER 2014 Networking for success: A burning platform in Berkshire West SUMMARY In 2012, four federated CCGs set up a network to redesign diabetes services in Berkshire
More informationWest Midlands Sarcoma Advisory Group
West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Specialist Sarcoma Multi Disciplinary Team for Suspected Bone Sarcoma Version History Version Date Brief Summary
More informationMinutes of the meeting of the Responsible Gambling Strategy Board held on 23 May 2013
RGSB 13 03 Minutes of the meeting of the Responsible Gambling Strategy Board held on 23 May 2013 Venue: Government Art Collection, Queens Yard, 179a Tottenham Court Road, London, W1T 7PA Time: 10.15 Present:
More informationCosting report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)
Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:
More information2016 Re-Audit of Patient Blood Management in adults undergoing elective, scheduled surgery
2016 Re-Audit of Patient Blood Management in adults undergoing elective, scheduled surgery 2017 Re-Audit of Red Cell & Platelet Transfusion in Adult Haematology patients South West RTC 2016 Re-Audit of
More informationBreast Cancer Pathway Board Minutes of meeting
Breast Cancer Pathway Board Minutes of meeting Monday 9 th March 2015, 2pm 5 pm Boardroom 1, New Alderley House, Victoria Road, East Cheshire NHS Foundation Trust Attendance Mohammed Absar Chandeena Roshanlall
More informationHaematology Regional Group Meeting Monday 18 th October 2010, Antrim Hospital
Haematology Regional Group Meeting Monday 18 th October 2010, Antrim Hospital In attendance: Dr Anne Kyle Clinical Lead Ms Sarah Taggart Ms Caroline McCaughey Ms Margaret Michael Dr Robert Cuthbert Ms
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical
More informationReferral and Ongoing Care for Children with Suspected Diabetes
South West Paediatric Diabetes Regional Network Pathway for Referral and Ongoing Care for Children with Suspected Diabetes Dear Colleagues, On behalf of the South West Paediatric Diabetes Network, I m
More informationHaematology Advisory Group Meeting
Haematology Advisory Group Meeting 19 November 2003 Meeting Room Velindre NHS Trust Corporate Headquarters Parc Nantgarw Present Dr HW Habboush Chairman Dr A Al-Sabah Consultant Haematologist Cardiff and
More informationSummary Notes from Anxiety and Depression Network Patient Forum 16 th September
Summary Notes from Anxiety and Depression Network Patient Forum 16 th September 4-6.30, High Wycombe Holiday Inn Present: Ailsa Harrison (Patient Representative on A&D Network Steering Group), Ineke Wolsey
More information